Bank Julius Baer & Co. Ltd Zurich Sells 4,335 Shares of Cardinal Health, Inc. $CAH

Bank Julius Baer & Co. Ltd Zurich lessened its position in Cardinal Health, Inc. (NYSE:CAH) by 20.7% during the fourth quarter, Holdings Channel reports. The fund owned 16,657 shares of the company’s stock after selling 4,335 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Cardinal Health were worth $3,445,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Aventura Private Wealth LLC bought a new position in Cardinal Health in the fourth quarter valued at $25,000. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. JPL Wealth Management LLC bought a new position in Cardinal Health in the third quarter valued at $31,000. Turning Point Benefit Group Inc. bought a new position in Cardinal Health in the third quarter valued at $31,000. Finally, American Capital Advisory LLC boosted its position in Cardinal Health by 5,200.0% during the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.4%

Cardinal Health stock opened at $195.10 on Friday. The firm has a 50-day moving average of $206.96 and a 200-day moving average of $207.79. The firm has a market cap of $45.69 billion, a P/E ratio of 29.83, a P/E/G ratio of 1.15 and a beta of 0.53. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several analyst reports. Leerink Partners restated an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Citigroup cut their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research report on Friday, May 1st. William Blair initiated coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Finally, Jefferies Financial Group upped their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.